1. Introduction
===============

*Panax ginseng* C.A. Meyer has been used in China for thousands of years as a traditional medicine and proved to exhibit wide pharmacological properties, such as anti-fatigue, anti-diabetes, as well as activity in the prevention of cancer and the ageing process \[[@B1-molecules-15-02319],[@B2-molecules-15-02319],[@B3-molecules-15-02319],[@B4-molecules-15-02319]\]. The major components contributing to its pharmacology activities were considered to be the ginsenosides, a group of steroidal saponins. Around 40 ginsenosides have been isolated and characterized till now, including the recent identified ginsenosides Ki and Km \[[@B5-molecules-15-02319]\]. Among these known compounds, malonylginsenosides are natural ginsenosides that exist in both fresh and air-dried ginseng roots and which contain malonyl residues attached to the glucose units of the corresponding neutral ginsenosides \[[@B6-molecules-15-02319]\]. Kitagawa *et al*. and Yamaguchi *et a*l. reported the presence of four acidic ginsenosides both in Asian and American ginseng \[[@B7-molecules-15-02319],[@B8-molecules-15-02319]\]. Our previous pharmacology results showed that total malonyl-ginsenosides exhibit hypoglycemic effects on streptozotocin-induced diabetic mice \[[@B9-molecules-15-02319]\]. During our continued studies on bioactive compounds from *Panax ginseng* \[[@B10-molecules-15-02319],[@B11-molecules-15-02319],[@B12-molecules-15-02319]\], a novel ginsenoside, namely malonylginsenoside Ra~3~ (compound **1**), was isolated from a methanolic extraction of the fresh roots of *Panax ginseng*. This paper describes the isolation and structure determination of the new compound **1** ([Figure 1](#molecules-15-02319-f001){ref-type="fig"}).

![The structures of the isolated ginsenosides.](molecules-15-02319-g001){#molecules-15-02319-f001}

2. Results and Discussion
=========================

A crude methanolic extract of the fresh roots of *Panax ginseng* was subjected to open column chromatography on silica gel and then purified by preparative HPLC, to yield five ginsenosides, one of which, namely malonylginsenoside Ra~3~ (compound **1**), was new. The other four saponins were identified as known malonylginsenoside*-*Rb~1~ (compound **2**), malonylginsenoside*-*Rb~2~ (compound **3**), malonylginsenoside*-*Rc (compound **4**) and malonylginsenoside*-*Rd (compound **5**) by comparison of NMR data with those in the literature \[[@B6-molecules-15-02319]\] and by comparison with authentic sample by ESI-MS, optical rotation and TLC.

Characterization of compound ***1***
------------------------------------

Compound **1** was obtained as a white amorphous powder and gave a peaks at *m/z* 1325.4 \[M-H\]^-^, 1281 \[M-CO~2~\]^-^, 1239 \[M-COCH~2~COOH\]^-^, 1107 \[M-COCH~2~COOH-xyl\]^-^, 945 \[M-COCH~2~COOH-glc-xyl\]^-^, 783 \[M-COCH~2~COOH-xyl-2glc-H\]^-^, 621 \[M-COCH~2~COOH-xyl-3glc-H\]^-^, 459 \[M-COCH~2~COOH-xyl-4glc-H\]^-^, in the negative ESI-MS, indicating its molecular weight to be 1326. The molecular formula was determined as C~62~H~102~O~30~ based on HRESI-MS \[M+Na\]^+^: *m/z* 1349.6348 \[M+Na\]^+^ (calcd. for C~62~H~102~NaO~30~, 1349.6353). IR (KBr) *ν*~max~/cm^-1^: 3423 cm^-1^ (OH), 1732 cm^-1^ (C=O), 1608 (C=C) and 1386 cm^-1^ (-CH~3~). Since compound **1** can't be dissolved in pyridine-*d*~5~, we added 0.1 mL of D~2~O in 0.5 mL of pyridine-*d*~5~ as NMR solvent. Ginsenoside m-Rb~1~ (compound **2**) and the alkaline hydrolysis product of **1**, ginsenoside Ra~3~ (compound **1a**) were also dissolved in the same mixture solvent for NMR measurement. Analysis of the ^13^C-NMR spectrum ([Table 1](#molecules-15-02319-t001){ref-type="table"}) and DEPT experiments, allowed the identification of eight methyl groups and six quaternary carbons.
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The^13^C-NMR data of compounds **1, 2** and **1a**.^a^

                 1       2       1a               1       2       1a
  -------------- ------- ------- ------- -------- ------- ------- -------
  C-1            40.0    40.1    39.3    3-Glu                    
  C-2            27.7    27.6    26.7    C-1'     105.5   105.8   105.0
  C-3            90.9    90.7    89.0    C-2'     85.1    84.8    83.5
  C-4            40.6    40.6    39.6    C-3'     78.5    78.5    78.0
  C-5            57.4    57.4    56.5    C-4'     72.2    72.2    71.6
  C-6            19.4    19.4    18.4    C-5'     78.5    78.8    78.0
  C-7            36.0    36.0    35.1    C-6'     63.4    63.4    62.8
  C-8            40.9    41      40.0    Glu                      
  C-9            51.0    51.1    50.1    C-1"     106.3   106.5   105.9
  C-10           37.8    37.8    36.8    C-2"     77.4    77.5    77.1
  C-11           31.2    31.3    30.9    C-3"     79.5    79.4    79.2
  C-12           71.0    70.9    70.1    C-4"     71.6    71.7    71.6
  C-13           50.0    50.2    49.3    C-5"     75.7    75.8    78.0
  C-14           52.5    52.4    51.4    C-6"     66.1    66.1    62.8
  C-15           31.8    31.9    30.9    20-Glu                   
  C-16           27.7    27.6    26.6    C-1'     98.7    98.8    98.1
  C-17           52.8    52.8    51.7    C-2'     75.3    75.6    74.8
  C-18           17.2    17.2    16.3    C-3'     78.5    78.8    78.0
  C-19           16.9    16.9    16.0    C-4'     72.2    72.2    71.6
  C-20           85.2    85.0    83.5    C-5'     77.4    77.2    77.1
  C-21           23.3    23.3    22.7    C-6'     70.4    72      69.6
  C-22           37.2    37.1    36.1    Glu                      
  C-23           24.3    24.2    23.3    C-1"     105.5   105.6   105.0
  C-24           126.7   126.8   126.0   C-2"     74.7    75.6    74.2
  C-25           132.8   132.6   130.8   C-3"     88.0    78.8    87.4
  C-26           26.9    26.8    25.8    C-4"     71.7    72.2    71.3
  C-27           19.0    19.0    17.9    C-5"     78.5    78.8    78.0
  C-28           29.0    29.0    28.1    C-6"     63.0    63.4    62.4
  C-29           17.5    17.5    16.5    Xyl                      
  C-30           18.3    18.3    17.3    C-1'''   106.6           106.2
  -O-[C]{.ul}O   172.1   171.9           C-2'''   75.7            75.2
  [C]{.ul}H~2~   41.9    41.9            C-3'''   77.4            77.1
  [C]{.ul}OOH    174.6   174.5           C-4'''   71.2            70.8
                                         C-5'''   67.8            67.2

^a^ Compounds **1**, **1a**and **2** were measured in C~5~N~5~-*d*~6~(0.5 mL) plus D~2~O (0.1 mL).

The ^1^H- and ^13^C-NMR spectroscopic data of compound **1** were similar to those of ginsenoside-Ra~3~ \[[@B13-molecules-15-02319]\], except the data attributed to a malonyl group (*δ*~H~ 3.70, *δ*~C~ 172.1, *δ*~C~ 174.6). The malonyl group was assigned to C~3~-glc-C-6'' position by HMBC experiment ([Figure 2](#molecules-15-02319-f002){ref-type="fig"}), which the protons of C~3~-glc-H-6'' showed HMBC correlations with malonyl group (*δ*~C~ 172.1).

![Partial HMBC correlation of compound **1**.](molecules-15-02319-g002){#molecules-15-02319-f002}

Malonyl group connection also caused a 2.7 ppm lower-field shift for C~3~-glc-C-6'' (*δ*~C~ 66.1) than seen in ginsenoside-Ra~3~. Alkaline hydrolysis of compound **1** yield compound **1a**, which showed the structure identical to ginsenoside Ra~3~ by 1D NMR analysis ([Table 1](#molecules-15-02319-t001){ref-type="table"}). The absolute configurations of the sugar moieties were further determined to be β-[D]{.smallcaps}-glucose and β-[D]{.smallcaps}-xylose by chiral GC analysis. The 20 position was determined as *S* conformation due to its similar NMR data with the known compounds **1a** and **2**. All the data above led us to identified the structure of **1** as (20*S*)-protopanaxadiol 3-*O*-(6-*O*-malonyl-*β*-[D]{.smallcaps}-glucopyranosyl(1→2)-*β*-[D]{.smallcaps}-glucopyranoside)-20-*O*-*β*-[D]{.smallcaps}-xylopyranosyl(1→3)-*β*-[D]{.smallcaps}-glucopyranosyl(1→6)-*β*-D-glucopyranoside, which we have named malonylginsenoside Ra~3~.

3. Experimental
===============

3.1. General
------------

The ^1^H- and ^13^C-NMR spectra were measured on a Bruker Avance DRX 500 NMR spectrometer, using TMS as an internal standard. Chemical shifts (*δ*) are expressed in parts per million (ppm), with the coupling constants (*J*) reported in Hertz (Hz). The ESI-MS spectra were recorded on a triple quadrupole mass spectrometer Quattro (VG Biotech, Altrincham, England) and the HRESI-MS spectra on a Bruker FT-ICRMS spectrometer. Column chromatographies were carried out with silica gel 60 M (200--300 mesh), Lichrospher RP-18 (20 μm); TLC was performed with silica gel plates (Macherey-Nagel, SilG/UV~254~, 0.20 mm), with spots detected by UV~254~ and H~2~SO~4~ (10%). HPLC were carried out with a Agilent 1100 system.

3.2. Plant material
-------------------

The fresh root of *Panax ginseng* was collected from Fu-Song, Jilin, China, in August 2003, and identified by one of the authors, Prof. Yi-Nan Zheng. A voucher specimen (ZYC-RS-03-08) has been deposited in College of Chinese Medicinal Material, Jilin Agricultural University.

3.3. Extraction and isolation
-----------------------------

The root of *Panax ginseng* (10 kg) was extracted five times with MeOH-H~2~O (4:1), and the extract was concentrated under reduced pressure at 40 °C. The residue (\~2 kg) obtained was suspended in water and subjected to D-101 resin column chromatography, using MeOH-H~2~O (0:1, 3:2) as eluted solvent to give total-ginsenoside (\~300 g). The total-ginsenoside was applied to silica gel column and eluted with CHCl~3~-MeOH-H~2~O (6:4:1) to yield three fractions (F~1~-F~3~). Fraction F~1~ was further chromatographed on preparative HPLC eluted with gradient CH~3~CN-H~2~O (20% to 50%) to give the known saponins: malonylginsenoside*-*Rb~1~ (compound **2**, 100 mg), malonylginsenoside*-*Rb~2~ (compound **3**, 60 mg), malonylginsenoside*-*Rc (compound **4**, 65 mg), malonylginsenoside*-*Rd (compound **5**, 42 mg) and the new saponin malonylginsenoside Ra~3~ (compound **1**, 40 mg). Compound 1: ^1^H-NMR (400 MHz, 0.5 mL pyridine-*d*~5~ + 0.1 mL D~2~O, ppm): *δ* 0.73 (3H, *s*, H-19), 0.87 (3H, *s*, H-18), 0.95 (3H, *s*, H-30), 0.98 (3H, *s*, H-29), 1.17 (3H, *s*, H-28), 1.63 (3H, *s*, H-21), 1.65 (3H, *s*, H-26), 1.69 (3H, *s*, H-27), 5.29 (1H, *t-like*, H-24), 5.11 (1H, *d*, *J* = 7.2 Hz, C~20~-glc-H-1'), 4.93 (1H, *d*, *J* = 7.2 Hz, C~20~-glc-H-1'') 4.85 (1H, *d*, *J* = 7.6 Hz, C~20~-xyl-H-1'''), 4.81 (1H, *d*, *J* = 7.8 Hz, C~3~-glc-H-1'), 5.19 (1H, *d*, *J* = 7.6 Hz,C~3~-glc-H-1''); ^13^C-NMR data, see [Table 1](#molecules-15-02319-t001){ref-type="table"}.

3.4. Alkaline hydrolysis of compound ***1***
--------------------------------------------

A solution of **1** (20 mg) in MeOH (3 mL) was treated with 5% KOH-MeOH (0.1 mL) and the whole mixture was stirred at room temperature (22 °C) for 30 min \[[@B6-molecules-15-02319]\]. The reaction mixture was neutralized with cation exchange resin (SP20ss, Resindion S.R.L., Rome, Italy) and filtered. Removal of the solvent from the filtrate under reduced pressure gave a product which was purified by column chromatography with reversed-phase silica gel (Zorbax SB-C~18~) to furnish compound **1a**, which was determined to be identical with an authentic sample \[[@B6-molecules-15-02319]\] by TLC comparison \[CHCl~3~-MeOH-H~2~O (65:35:10, lower phase), *n*-BuOH-AcOH-H~2~O (4:1:5 upper phase)\], IR(KBr), MS and ^13^C NMR spectral comparisons. Compound **1a**: IR (KBr) *ν*~max~ / cm^-1^: 3432, 1728, 1605, 1385, 1078; ESI-MS \[-\]: m/z = 1239 \[M-H\]^-^, 1107 \[M-xyl\]^-^, 945 \[M-glc-xyl\]^-^, 783 \[M-xyl-2glc-H\]^-^, 621 \[M-xyl-3glc-H\]^-^, 459 \[M-xyl-4glc-H\]^-^; ^1^H-NMR (400MHz, 0.5 mL pyridine-*d*~5~, ppm): *δ* 0.70 (3H, *s*, H-19), 0.84 (3H, *s*, H-18), 0.86 (3H, *s*, H-30), 0.96 (3H, *s*, H-29), 1.17 (3H, *s*, H-28), 1.49 (3H, *s*, H-21), 1.55 (3H, *s*, H-26), 1.58 (3H, *s*, H-27), 5.20 (1H, *t*, H-24), 5.04 (1H, *d*, *J* = 7.5 Hz, C~20~-glc-H-1'), 4.4.96 (1H, *d*, *J* = 7.6 Hz, C~20~-glc-H-1'') 4.83 (1H, *d*, *J* = 7.6 Hz, C~20~-xyl-H-1'''), 4.80 (1H, *d*, *J* = 7.8 Hz, C~3~-glc-H-1'), 5.26 (1H, *d*, *J* = 7.6 Hz, C~3~-glc-H-1''); ^13^C-NMR data, see [Table 1](#molecules-15-02319-t001){ref-type="table"}.

3.5. Acid hydrolysis of compound ***1***
----------------------------------------

To determine the stereochemistry of sugar moiety, compound **1** (2.0 mg) was refluxed with 6 N HCl (5 mL) at 100 °C for 2 h \[[@B14-molecules-15-02319],[@B15-molecules-15-02319]\]. The mixture was extracted with CHCl~3~ to afford the aglycone, and the aqueous layer was neutralized with Na~2~CO~3~ and filtered. The aqueous layer was dried under vacuum and the residue was re-dissolved in H~2~O for sugar analysis by TLC with *n*-BuOH-AcOH-H~2~O (4:1:2) as the solvent. The sample spots were detected by spraying aniline hydrogen phthalate reagent (100 mL *n*-BuOH saturated by H~2~O, 0.96 g aniline and 1.66 g phthalic acid) and heating at 120 °C. [D]{.smallcaps}-Glucose and [D]{.smallcaps}-xylose were used as authentic standards. The absolute configuration of glucose was further determined by chiral GC analysis using a SatoChrom GC and a 0.25 mm × 25 m Hydrodexb-6-TBDM chiral capillary column (Macherey-Nagel, Germany). *β*-[D]{.smallcaps}-Glucose and *β*-[D]{.smallcaps}-xylose were used as an authentic GC standard. The aqueous layer residues mentioned above were re-suspended in dichloromethane (1 mL), and trifluoroacetic anhydride (50 µL) was added. The mixtures were allowed to react at room temperature overnight and dried under a stream of nitrogen at room temperature. The sugar derivatives were separated using the following temperature program: inlet temperature was set at 240 °C, with hydrogen carrier gas and a 1/20 split, using nitrogen makeup gas. Column temperatures started at 120 °C, ramped to 220 °C at 50 °C·min^--1^ and were maintained for 12 min.

4. Conclusion
=============

A phytochemical investigation on the fresh root of *Panax ginseng* led to the isolation of a new saponin (20*S*)-protopanaxadiol 3-O-(6-O-malonyl-*β*-D-glucopyranosyl(1→2)-*β*-D-glucopyranoside)-20-O-*β*-D-xylopyranosyl(1→3)-*β*-D-glucopyranosyl(1→6)-*β*-D-glucopyranoside (**1**) along with four known ginsenosides (**2**--**5**).
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